Skip to main content

Advertisement

Log in

Accuracy of focal cystic appearance within adrenal nodules on contrast-enhanced CT to distinguish pheochromocytoma and malignant adrenal tumors from adenomas

  • Kidneys, Ureters, Bladder, Retroperitoneum
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To determine the accuracy of cystic appearance within adrenal masses on contrast-enhanced CT in distinguishing pheochromocytomas and malignant adrenal tumors from adenomas.

Methods

We performed a retrospective review of adult patients with pathologically proven adrenal tumors who underwent contrast-enhanced abdominal CT. There were 92 patients (mean age 64.7 years, 52 men) with 22 pheochromocytomas, 34 malignant masses, and 36 adenomas. Two abdominal radiologists independently reviewed CT images to determine the presence of cystic appearance within the adrenal masses, defined as focal regions of low attenuation within the tumor that subjectively had fluid density.

Results

Cystic appearance was present in 12/22 (55%, 95% CI 32–76%) pheochromocytomas (mean size 5.3 cm), 15/34 (44%, 95% CI 27–62%) malignant masses (mean size 5.8 cm), and 2/36 (5.6%, 95% CI 0.7–9%) adenomas (mean size 3.2 cm). Sensitivity and specificity of cystic appearance for distinguishing pheochromocytoma or malignant masses from adenomas were 48.2% (95% CI 34.7–62.0%) and 94.4% (95% CI 81.3–99.3%), respectively. Cystic appearance was a significant predictor of tumor type (p = 0.015) even after controlling for tumor size. Reader agreement for cystic appearance was almost perfect with a kappa of 0.85.

Conclusion

Cystic appearance in adrenal tumors on contrast-enhanced CT has high specificity and low sensitivity for distinguishing pheochromocytoma and malignant adrenal masses from adenomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. Journal of endocrinological investigation 29 (4):298-302. https://doi.org/10.1007/BF03344099

    Article  CAS  PubMed  Google Scholar 

  2. Young WF, Jr. (2007) Clinical practice. The incidentally discovered adrenal mass. The New England journal of medicine 356 (6):601–610. https://doi.org/10.1056/NEJMcp065470

  3. Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR American journal of roentgenology 190 (5):1163-1168. https://doi.org/10.2214/AJR.07.2799

    Article  PubMed  Google Scholar 

  4. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. European journal of endocrinology 175 (2):G1-G34. https://doi.org/10.1530/EJE-16-0467

    Article  CAS  PubMed  Google Scholar 

  5. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. European journal of endocrinology 149 (4):273-285. https://doi.org/10.1530/eje.0.1490273

    Article  CAS  PubMed  Google Scholar 

  6. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. The Journal of clinical endocrinology and metabolism 85 (2):637–644. https://doi.org/10.1210/jcem.85.2.6372

  7. Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J, Otto M, Cichocki A, Cwikla J, Slapa R, Eisenhofer G (2006) 1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors. Annals of the New York Academy of Sciences 1073:38-46. https://doi.org/10.1196/annals.1353.004

    Article  CAS  PubMed  Google Scholar 

  8. Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J, American Association of Clinical E, American Association of Endocrine S (2009) The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 15 Suppl 1:1-20. https://doi.org/10.4158/EP.15.S1.1

    Article  Google Scholar 

  9. Kahramangil B, Kose E, Remer EM, Reynolds JP, Stein R, Rini B, Siperstein A, Berber E (2020) A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 Patients. Annals of surgery. https://doi.org/10.1097/SLA.0000000000004048

    Article  PubMed  Google Scholar 

  10. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF, Jr., Endocrine S (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism 99 (6):1915-1942. https://doi.org/10.1210/jc.2014-1498

    Article  CAS  PubMed  Google Scholar 

  11. Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2018) Pheochromocytoma as a frequent false-positive in adrenal washout CT: A systematic review and meta-analysis. European radiology 28 (3):1027-1036. https://doi.org/10.1007/s00330-017-5076-5

    Article  PubMed  Google Scholar 

  12. Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N, Chaffanjon P (2004) Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. European journal of endocrinology 150 (5):681-686. https://doi.org/10.1530/eje.0.1500681

    Article  CAS  PubMed  Google Scholar 

  13. Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH (2005) Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR American journal of roentgenology 185 (3):684-688. https://doi.org/10.2214/ajr.185.3.01850684

    Article  PubMed  Google Scholar 

  14. Pourian M, Mostafazadeh DB, Soltani A (2015) Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. Journal of diabetes and metabolic disorders 15:11. https://doi.org/10.1186/s40200-016-0230-1

    Article  CAS  PubMed  Google Scholar 

  15. Corwin MT, Arora A, Loehfelm TW, Fananapazir G, Campbell MJ (2020) Adherence to guidelines for hormonal evaluation in patients with incidentally detected adrenal nodules: effects of radiology report wording and standardized reporting. Abdominal radiology. https://doi.org/10.1007/s00261-020-02517-3

    Article  PubMed  Google Scholar 

  16. Bujawansa S, Bowen-Jones D (2011) Low investigation rate for adrenal incidentalomas. Endocrine 40 (1):134-136. https://doi.org/10.1007/s12020-011-9487-9

    Article  CAS  PubMed  Google Scholar 

  17. Davenport E, Lang Ping Nam P, Wilson M, Reid A, Aspinall S (2014) Adrenal incidentalomas: management in British district general hospitals. Postgraduate medical journal 90 (1065):365-369. https://doi.org/10.1136/postgradmedj-2013-132386

    Article  PubMed  Google Scholar 

  18. de Haan RR, Schreuder MJ, Pons E, Visser JJ (2019) Adrenal Incidentaloma and Adherence to International Guidelines for Workup Based on a Retrospective Review of the Type of Language Used in the Radiology Report. Journal of the American College of Radiology : JACR 16 (1):50-55. https://doi.org/10.1016/j.jacr.2018.08.011

    Article  PubMed  Google Scholar 

  19. Eldeiry LS, Alfisher MM, Callahan CF, Hanna NN, Garber JR (2018) The impact of an adrenal incidentaloma algorithm on the evaluation of adrenal nodules. Journal of clinical & translational endocrinology 13:39-45. https://doi.org/10.1016/j.jcte.2018.07.001

    Article  Google Scholar 

  20. Eldeiry LS, Garber JR (2008) Adrenal incidentalomas, 2003 to 2005: experience after publication of the National Institutes of Health consensus statement. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 14 (3):279-284. https://doi.org/10.4158/EP.14.3.279

    Article  Google Scholar 

  21. Sahni P, Trivedi A, Omer A, Trivedi N (2016) Adrenal incidentalomas: are they being worked up appropriately? Journal of community hospital internal medicine perspectives 6 (5):32913. https://doi.org/10.3402/jchimp.v6.32913

    Article  PubMed  Google Scholar 

  22. Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeney AT, Mueller PR, Hahn PF, Boland GW (2004) Pheochromocytoma: an imaging chameleon. Radiographics : a review publication of the Radiological Society of North America, Inc 24 Suppl 1:S87–99. https://doi.org/10.1148/rg.24si045506

  23. Park BK, Kim CK, Kwon GY, Kim JH (2007) Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features. European radiology 17 (11):2804-2809. https://doi.org/10.1007/s00330-007-0695-x

    Article  PubMed  Google Scholar 

  24. Northcutt BG, Raman SP, Long C, Oshmyansky AR, Siegelman SS, Fishman EK, Johnson PT (2013) MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma? AJR American journal of roentgenology 201 (4):834-839. https://doi.org/10.2214/AJR.12.9753

    Article  PubMed  Google Scholar 

  25. Song JH, Grand DJ, Beland MD, Chang KJ, Machan JT, Mayo-Smith WW (2013) Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone? AJR American journal of roentgenology 201 (6):1248-1253. https://doi.org/10.2214/AJR.12.10302

    Article  PubMed  Google Scholar 

  26. Andreoni C, Krebs RK, Bruna PC, Goldman SM, Kater CE, Alves MT, Ortiz V (2008) Cystic phaeochromocytoma is a distinctive subgroup with special clinical, imaging and histological features that might mislead the diagnosis. BJU Int 101 (3):345-350. https://doi.org/10.1111/j.1464-410X.2007.07370.x

    Article  PubMed  Google Scholar 

  27. Raja A, Leung K, Stamm M, Girgis S, Low G (2013) Multimodality imaging findings of pheochromocytoma with associated clinical and biochemical features in 53 patients with histologically confirmed tumors. AJR American journal of roentgenology 201 (4):825-833. https://doi.org/10.2214/AJR.12.9576

    Article  PubMed  Google Scholar 

  28. Newhouse JH, Heffess CS, Wagner BJ, Imray TJ, Adair CF, Davidson AJ (1999) Large degenerated adrenal adenomas: radiologic-pathologic correlation. Radiology 210 (2):385-391. https://doi.org/10.1148/radiology.210.2.r99fe12385

    Article  CAS  PubMed  Google Scholar 

  29. Park SY, Park BK, Park JJ, Kim CK (2015) CT sensitivities for large (>/=3 cm) adrenal adenoma and cortical carcinoma. Abdom Imaging 40 (2):310-317. https://doi.org/10.1007/s00261-014-0202-1

    Article  PubMed  Google Scholar 

  30. Mayo-Smith WW, Song JH, Boland GL, Francis IR, Israel GM, Mazzaglia PJ, Berland LL, Pandharipande PV (2017) Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. Journal of the American College of Radiology : JACR 14 (8):1038-1044. https://doi.org/10.1016/j.jacr.2017.05.001

    Article  PubMed  Google Scholar 

  31. Dabbous A, Siddik-Sayyid S, Baraka A (2007) Catastrophic hemodynamic changes in a patient with undiagnosed pheochromocytoma undergoing abdominal hysterectomy. Anesth Analg 104 (1):223-224. https://doi.org/10.1213/01.ane.0000249812.87527.91

    Article  PubMed  Google Scholar 

  32. Tarant NS, Dacanay RG, Mecklenburg BW, Birmingham SD, Lujan E, Green R (2006) Acute appendicitis in a patient with undiagnosed pheochromocytoma. Anesth Analg 102 (2):642-643. https://doi.org/10.1213/01.ane.0000184827.79120.43

    Article  PubMed  Google Scholar 

  33. Myklejord DJ (2004) Undiagnosed pheochromocytoma: the anesthesiologist nightmare. Clin Med Res 2 (1):59-62. https://doi.org/10.3121/cmr.2.1.59

    Article  PubMed  PubMed Central  Google Scholar 

  34. Holldack HJ (2007) Induction of anesthesia triggers hypertensive crisis in a patient with undiagnosed pheochromocytoma: could rocuronium be to blame? J Cardiothorac Vasc Anesth 21 (6):858-862. https://doi.org/10.1053/j.jvca.2006.11.007

    Article  PubMed  Google Scholar 

  35. O'Riordan JA (1997) Pheochromocytomas and anesthesia. Int Anesthesiol Clin 35 (4):99-127

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number UL1 TR001860. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael T. Corwin.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Corwin, M.T., Mitchell, A.S., Wilson, M. et al. Accuracy of focal cystic appearance within adrenal nodules on contrast-enhanced CT to distinguish pheochromocytoma and malignant adrenal tumors from adenomas. Abdom Radiol 46, 2683–2689 (2021). https://doi.org/10.1007/s00261-020-02925-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02925-5

Keywords

Navigation